Retiform Purpura of the Lower Limbs Associated with Levamisole-Adulterated Cocaine.

Cocaine antiphospholipid syndrome levamisole retiform purpura vasculitis

Journal

European journal of case reports in internal medicine
ISSN: 2284-2594
Titre abrégé: Eur J Case Rep Intern Med
Pays: Italy
ID NLM: 101648453

Informations de publication

Date de publication:
2022
Historique:
received: 13 04 2022
accepted: 19 04 2022
entrez: 6 5 2022
pubmed: 7 5 2022
medline: 7 5 2022
Statut: epublish

Résumé

A young man was treated in hospital for sepsis, disseminated intravascular coagulation and multi-organ failure. He was a regular intranasal cocaine user up to 1 day prior to symptom onset. Clinical examination revealed extensive retiform purpura affecting both his lower limbs. Skin biopsy revealed widespread thrombosis in the small- and medium-sized vessels of the mid dermis and the subcutaneous fat with surrounding leucocytoclasis. There was also extensive ischaemic necrosis of the upper reticular and papillary dermis and focal ischaemic necrosis of the epidermis. These findings were in keeping with a thrombotic vasculopathy with associated cutaneous ischaemic necrosis, likely associated with levamisole-adulterated cocaine (LAC). An autoimmune screen showed extremely raised levels of anti-B2-glycoprotein IgM, IgG and anti-cardiolipin IgG antibodies, usually seen in antiphospholipid syndrome (APS). The literature describes how APS could be secondary to various underlying conditions, including LAC, and that levamisole toxicity may mimic APS and hence be missed. Levamisole is a common adulterant found in cocaine; the resultant toxicity can present with cutaneous manifestations, namely retiform purpura and skin necrosis, similar to antiphospholipid syndrome.Patients presenting with such features should be asked about illicit drug use, specifically cocaine, and investigated by screening urine for drugs of abuse and serum antihuman elastase antibody when possible.

Identifiants

pubmed: 35520371
doi: 10.12890/2022_003353
pii: 3353-1-28512-1-10-20220427
pmc: PMC9067424
doi:

Types de publication

Journal Article

Langues

eng

Pagination

003353

Informations de copyright

© EFIM 2022.

Déclaration de conflit d'intérêts

Conflicts of Interests: The Authors declare that there are no competing interest

Références

J Thromb Thrombolysis. 2012 Jul;34(1):7-10
pubmed: 22437653
Am J Dermatopathol. 2013 Oct;35(7):722-30
pubmed: 23392134
WMJ. ;116(1):37-9
pubmed: 29099568
Dermatol Online J. 2011 Apr 15;17(4):12
pubmed: 21549087
Rheumatology (Oxford). 2015 Aug;54(8):1533-4
pubmed: 26070938

Auteurs

Stephanie Farrugia (S)

Department of General Medicine, Mater Dei Hospital, Msida, Malta.

Daniel Micallef (D)

Department of Dermatology, Mater Dei Hospital, Msida, Malta.

David Pisani (D)

Department of Pathology, Mater Dei Hospital, Msida, Malta.

Alexandra Betts (A)

Department of Pathology, Mater Dei Hospital, Msida, Malta.

Sandro Vella (S)

Department of Endocrinology, Diabetes and General Medicine, Mater Dei Hospital, Msida, Malta.

Michael J Boffa (MJ)

Department of Dermatology, Mater Dei Hospital, Msida, Malta.

Classifications MeSH